GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data
16 juil. 2019 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in developing human vaccines, announced today that Senior...
GeoVax to Present at the American Society for Virology 2018 Annual Meeting
09 juil. 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, July 09, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” at the Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress,...